EGF and neoplasm: Additionally, the ERK1/2 and PI3K pathways have been reported to mediate increases in EGF-induced claudin-2 expression in colon cancer cells; this event was accompanied by increases in proliferation, anchorage-independent growth and tumor growth in vivo[22].